NasdaqGS - Delayed Quote USD

Geron Corporation (GERN)

1.5200
+0.0400
+(2.70%)
At close: May 30 at 4:00:01 PM EDT
1.5300
+0.01
+(0.66%)
After hours: May 30 at 7:49:19 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
116,293
76,994
237
596
1,393
Cost of Revenue
2,462
1,256
0
0
--
Gross Profit
113,831
75,738
237
596
--
Operating Expense
248,133
249,470
194,181
139,146
115,392
Operating Income
-134,302
-173,732
-193,944
-138,550
-113,999
Net Non Operating Interest Income Expense
-2,751
1,103
9,840
-4,353
-3,213
Other Income Expense
-1,964
-1,943
-23
1,002
1,100
Pretax Income
-139,017
-174,572
-184,127
-141,901
-116,112
Net Income Common Stockholders
-139,017
-174,572
-184,127
-141,901
-116,112
Diluted NI Available to Com Stockholders
-139,017
-174,572
-184,127
-141,901
-116,112
Basic EPS
-0.21
-0.27
-0.32
-0.37
-0.35
Diluted EPS
-0.21
-0.27
-0.32
-0.37
-0.35
Basic Average Shares
661,636.2520
646,033.2470
570,645.4050
380,784.8460
327,631.8140
Diluted Average Shares
661,636.2520
646,033.2470
570,645.4050
380,784.8460
327,631.8140
Total Operating Income as Reported
-134,302
-173,732
-193,944
-138,550
-113,999
Total Expenses
250,595
250,726
194,181
139,146
115,392
Net Income from Continuing & Discontinued Operation
-139,017
-174,572
-184,127
-141,901
-116,112
Normalized Income
-137,310
-172,865
-184,127
-141,901
-116,112
Interest Income
20,520
19,607
18,152
2,529
527
Interest Expense
23,271
18,504
8,312
6,882
3,740
Net Interest Income
-2,751
1,103
9,840
-4,353
-3,213
EBIT
-115,746
-156,068
-175,815
-135,019
-112,372
EBITDA
-114,492
-154,847
-174,782
-134,151
-111,589
Reconciled Cost of Revenue
2,462
1,256
0
0
--
Reconciled Depreciation
1,254
1,221
1,033
868
783
Net Income from Continuing Operation Net Minority Interest
-139,017
-174,572
-184,127
-141,901
-116,112
Total Unusual Items Excluding Goodwill
-1,707
-1,707
0
0
--
Total Unusual Items
-1,707
-1,707
0
0
--
Normalized EBITDA
-112,785
-153,140
-174,782
-134,151
-111,589
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 7/31/1996

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AGEN Agenus Inc.
3.4300
+7.19%
 
LCTX Lineage Cell Therapeutics, Inc.
0.6647
-3.10%
 
MAIA MAIA Biotechnology, Inc.
1.7900
-1.10%
 
ADMA ADMA Biologics, Inc.
19.84
+0.35%
 
IOVA Iovance Biotherapeutics, Inc.
1.7500
-4.37%
 
INCY Incyte Corporation
65.06
-1.48%
 
IBRX ImmunityBio, Inc.
2.6600
+2.31%
 
LXRX Lexicon Pharmaceuticals, Inc.
0.6266
-5.03%
 
FATE Fate Therapeutics, Inc.
1.2100
-8.33%
 
VSTM Verastem, Inc.
7.52
-3.22%